N
GBT

Nuveen’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Nuveen’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-589,525
Closed -$40.1M – 3319
2022
Q3 		$40.1M Sell
589,525
-60,744
-9% -$3.35M 0.02% 619
2022
Q2 		$20.8M Buy
650,269
+367,895
+130% +$10.8M 0.01% 1023
2022
Q1 		$9.08M Buy
282,374
+1,510
+0.5% +$45.1K ﹤0.01% 1709
2021
Q4 		$7.44M Buy
280,864
+83,125
+42% +$2.57M ﹤0.01% 1864
2021
Q3 		$5.54M Sell
197,739
-174,174
-47% -$5.12M ﹤0.01% 2144
2021
Q2 		$13M Sell
371,913
-180,921
-33% -$7.06M ﹤0.01% 1685
2021
Q1 		$22.5M Sell
552,834
-136,664
-20% -$6.28M 0.01% 1230
2020
Q4 		$29.9M Buy
689,498
+309,289
+81% +$15.2M 0.01% 976
2020
Q3 		$21M Buy
380,209
+182,224
+92% +$11.6M 0.01% 1031
2020
Q2 		$12.5M Sell
197,985
-78,377
-28% -$5.38M 0.01% 1335
2020
Q1 		$14.1M Buy
276,362
+18,077
+7% +$1.21M 0.01% 1090
2019
Q4 		$20.5M Sell
258,285
-237,320
-48% -$14.1M 0.01% 1148
2019
Q3 		$24M Buy
495,605
+276,402
+126% +$14.4M 0.01% 1035
2019
Q2 		$11.5M Buy
+219,203
New +$12.6M ﹤0.01% 1510

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Nuveen's GBT Position: Q4 2022 in Review

Nuveen sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 589,525 shares — an estimated $40.1M sold.

Nuveen first reported a position in GBT in Q2 2019 and held it in 14 quarters. The position peaked at $40.1M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Nuveen reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Nuveen sold 589,525 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $40.1M.
  • Nuveen first reported a position in Global Blood Therapeutics, Inc. in Q2 2019 and held it in 14 quarters.
  • Nuveen's Global Blood Therapeutics, Inc. position peaked at $40.1M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.